1. Home
  2. Labeler Index
  3. Pharmacosmos Therapeutics Inc.
  4. 73594-0101
  5. NDC Package Code: 73594-0101-1 Cosela

NDC Package 73594-0101-1 Cosela

Trilaciclib Injection, Powder, Lyophilized, For Solution Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
73594-0101-1
Package Description:
1 VIAL, GLASS in 1 CARTON / 20 mL in 1 VIAL, GLASS
Product Code:
73594-0101
Proprietary Name:
Cosela
Non-Proprietary Name:
Trilaciclib
Substance Name:
Trilaciclib Dihydrochloride
Usage Information:
COSELA is indicated to decrease the incidence of chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/etoposide-containing regimen or topotecan-containing regimen for extensive-stage small cell lung cancer (ES-SCLC).
11-Digit NDC Billing Format:
73594010101
NDC to RxNorm Crosswalk:
Product Type:
Human Prescription Drug
Labeler Name:
Pharmacosmos Therapeutics Inc.
Dosage Form:
Injection, Powder, Lyophilized, For Solution - A dosage form intended for the solution prepared by lyophilization ("freeze drying"), a process which involves the removal of water from products in the frozen state at extremely low pressures; this is intended for subsequent addition of liquid to create a solution that conforms in all respects to the requirements for Injections.
Administration Route(s):
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s):
TRILACICLIB DIHYDROCHLORIDE 300 mg/20mL
Pharmacologic Class(es):
Sample Package:
No
FDA Application Number:
NDA214200
Marketing Category:
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date:
08-25-2025
Listing Expiration Date:
12-31-2026
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 73594-0101-1?

The NDC Packaged Code 73594-0101-1 is assigned to a package of 1 vial, glass in 1 carton / 20 ml in 1 vial, glass of Cosela, a human prescription drug labeled by Pharmacosmos Therapeutics Inc.. The product's dosage form is injection, powder, lyophilized, for solution and is administered via intravenous form.

Is NDC 73594-0101 included in the NDC Directory?

Yes, Cosela with product code 73594-0101 is active and included in the NDC Directory. The product was first marketed by Pharmacosmos Therapeutics Inc. on August 25, 2025 and its listing in the NDC Directory is set to expire on December 31, 2026 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 73594-0101-1?

The 11-digit format is 73594010101. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-4-173594-0101-15-4-273594-0101-01